RE:RE:RE:RE:RE:RE:RE:RE:RE:focusing on c/y run rate is rather stupidgibbonsj wrote: We only started showing a profit two quarters ago and the market in general has had its ups and downs. Plenty of good companies out there that are showing a negative return at this time. It's clear that you don't know this but now is the time to be buying, when there's blood in the street. You'll thank me for enlightening you in this.
The markets are forward looking. Too bad co. did not disclose this in news release or MD&A. Why bury it in CC?
We are operating in an extremely bullish regulatory environment, which was most recently evidenced by the Medicare fee schedule adjustments resulting in a significant CPI increase for DME providers for calendar 2023 of 6.4% to 9.1%. The percentage depends on whether products serviced our competitive bidding program items or in former competitive bidding areas. This CPI adjustment is extremely meaningful for us in 2023 as we have seen margins stabilize and believe peak inflation has already run through our business to date. As a result, we believe that the CPI increase will have a materially favorable effect on our net income in calendar 2023.